Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction

American Journal of Emergency Medicine

Volumn 27, Issue 6, 2009, Pages 712-719

  De Luca, Giuseppe ^a   Cassetti, Ettore ^a   Marino, Paolo ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DUTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; RETEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

CLINICAL TRIAL; COMPARATIVE STUDY; DATA ANALYSIS; DATA EXTRACTION; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION; THERAPY DELAY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 67650076576     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.04.026     Document Type: Review

References (48)

1. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110 (2004) 588-636
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
3. Nallamothu B.K., and Bates E.R. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?. Am J Cardiol 92 (2003) 824-826
4. Nallamothu B.K., Antman E.M., and Bates E.R. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?. Am J Cardiol 94 (2004) 772-774
5. Betriu A., and Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. Am J Cardiol 95 (2005) 100-101
6. Tarantini G., Razzolini R., Ramondo A., et al. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 96 (2005) 1503-1505
7. Svensson L., Aasa M., Dellborg M., Gibson C.M., Kirtane A., Herlitz J., et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) Reperfusion Trial. Am Heart J 151 (2006) 798.e1-798.e7
8. Dieker H.J., van Horssen E.V., Hersbach F.M., Brouwer M.A., van Boven A.J., van't Hof A.W., et al. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). J Thromb Thrombolysis 22 (2006) 39-45
9. Dobrzycki S., Mezynski G., Kralisz P., Prokopczuk P., Nowak K., Kochman W., et al. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results. Kardiol Pol 64 (2006) 793-799
10. Dobrzycki S., Kralisz, Nowak K., et al. Transfer for primary PCI with GP IIb/IIIa inhibitor versus on-site thrombolysis in patients with acute myocardial infarction. One year follow-up of randomised open-label study. Eur Heart J 26 (2005) 464 [Abstract Supplement]
11. Armstrong P.W. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-Elevation Myocardial Infarction Therapy) study. Eur Heart J 27 (2006) 1530-1538
12. Zijlstra F., de Boer M.J., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328 (1993) 680-684
13. Zijlstra F., Hoorntje J.C.A., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341 (1999) 1413-1419
14. Ribeiro E.E., Silva L.A., Carneiro R., et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 22 (1993) 376-380
15. Grinfeld L., Berrocal D., Belardi J., et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): a randomized trial in a community hospital in Argentina. J Am Coll Cardiol 27 Suppl (1996) A222
16. Zijlstra F., Beukema W.P., van't Hof A.W., et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 29 (1997) 908-912
17. Akhras F., Abu Ousa A., Swann G., et al. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a new cardiac unit. J Am Coll Cardiol 29 (1997) A235-A236
18. Widimsky P., Groch L Zelizko M., et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: the PRAGUE study. Eur Heart J 21 (2000) 823-831
19. de Boer M.J., Ottervanger J.P., van't Hof J.C.A.W., et al. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 39 (2002) 1723-1728
20. Widimsky P., Budesinsky T., Vorac D., et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 24 1 (2003) 94-104
21. DeWood M.A. Direct PTCA vs intravenous t-PA in acute myocardial infarction: results from a prospective randomized trial. Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium VI (1990), George Washington University, Washington
22. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
23. Gibbons R.J., Holmes D.R., Reeder G.S., et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 328 (1993) 685-691
24. Ribichini F., Steffenino G., Dellavalle A., et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol 32 (1998) 1687-1694
25. Garcia E., Elizaga J., Perez-Castellano N., et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 33 (1999) 605-611
26. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336 (1997) 1621-1628
27. Hochman J.S., Sleeper L.A., Webb J.B., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634
28. Le May M.R., Labinaz M., Davies R.F., et al. Stenting Versus Thrombolysis in Acute Myocardial Infarction Trial (STAT). J Am Coll Cardiol 37 (2001) 985-991
29. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360 (2002) 825-829
30. Schomig A., Kastrati A., Dirschinger J., et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 343 (2000) 385-391
31. Vermeer F., Oude Ophuis A.J., van der Berg E.J., et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 82 (1999) 426-431
32. Andersen H.R., Nielsen T.T., Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
33. Kastrati A., Mehilli J., Dirschinger J., et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359 (2002) 920-925
34. Aversano T., Aversano L.T., Passamani E., et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 287 (2002) 1943-1951
35. Grines C.L., Westerhausen D.R., Grines L.L., et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. J Am Coll Cardiol 39 (2002) 1713-1719
36. Widimsky P., Bilkova D., Penicka M., et al. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial. Eur Heart J (2007) [electronic publication ahead of print]
37. Grines CL. SENIOR PAMI: Primary PCI not better than lytic therapy in elderly patients. http://www.theheart.org/viewArticle.do?primaryKey=581549
38. Boersma E. The Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27 (2006) 779-788
39. De Luca G., Suryapranata H., Zijlstra F., van't Hof A.W., Hoorntje J.C., Gosselink A.T., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
40. Gersh B.J., Stone G.W., White H.D., and Holmes Jr. D.R. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?. JAMA 293 (2005) 979-986
41. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 343 8893 (1994) 311-322
42. Kent D.M., Ruthazer R., Griffith J.L., Beshansky J.R., Grines C.L., Aversano T., et al. Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. Am J Cardiol 99 (2007) 1384-1388
43. Pinto D.S., Kirtane A.J., Nallamothu B.K., Murphy S.A., Cohen D.J., Laham R.J., et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 114 (2006) 2019-2025
44. Stuck A.E., Egger M., Hammer A., Minder C.E., and Beck J.C. Home visits to prevent nursing home admission and functional decline in elderly people: systematic review and meta-regression analysis. JAMA 287 (2002) 1022-1028
45. Hooper L., Summerbell C.D., Higgins J.P., Thompson R.L., Clements G., Capps N., et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 3 (2001) CD002137
46. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Tcheng J.E., Neumann F.J., et al. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol 47 (2006) 685-686
47. Magid D.J., Calonge B.N., Rumsfeld J.S., Canto J.G., Frederick P.D., Every N.R., et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 284 (2000) 3131-3138
48. Vakili B.A., and Brown D.L. 1995 Coronary Angioplasty Reporting System of the New York State Department of Health. Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health). Am J Cardiol 91 (2003) 726-728